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Introduction
Chorioamnionitis correlates to preterm delivery,
especially prior to 30 weeks of gestation [1]. Infants
born to women with chorioamnionitis have an in-
creased incidence of neonatal sepsis, intraventricular
hemorrhage, necrotizing enterocolitis, and chronic lung
disease [1,2]. Among these complications of chorio-
amnionitis, Wilson-Mikity syndrome (WMS) is a specific
yet rare chronic lung disease that probably results from
a fetal immunologic response to intrauterine infection.
In this report, we present the case of a premature baby
who manifested classical WMS, which was assumed to
be correlated with maternal chorioamnionitis.
Case Report
A 33-year-old primigravida was admitted to a regional
hospital for tocolysis at 19 weeks of gestation due to
preterm uterine contractions. During hospitalization,
signs of infection were noted, including leukocytosis
(white blood cell count, WBC, 20,100/μL). Febrile
morbidity was not found. Bilateral urolithiasis and
hydronephrosis were also noted, yet urinalysis yielded
no pathogens. After parenteral clindamycin and ritodrine
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infusion, uterine contractions and leukocytosis sub-
sided and the patient was discharged. However, she
was re-admitted for tocolysis at 22 weeks of gestation.
Unfortunately, preterm premature rupture of mem-
branes occurred at 24 weeks of gestation. Amniotic
fluid culture yielded Pseudomonas aeruginosa. After con-
sulting an infection specialist, the empirical antibiotic
regimen was changed to ceftazidime, a third-generation
cephalosporin. Malodorous vaginal discharge and
fever were found at 26 weeks of gestation. Under the
threat of inevitable preterm birth and uncontrollable
P. aeruginosa infection, the patient was transferred to
our hospital for further management.
Upon arrival at our hospital, fetal monitors demon-
strated regular uterine contractions and a reactive fetal
heart rate. The cervix was 2 cm dilated. Sonography
revealed a fetus with vertex presentation. Fetal growth
was appropriate for gestational age. Almost no amniotic
fluid was found in the uterine cavity. Fever, remarkable
leukocytosis with left shift (WBC, 25,920/μL; 2.1%
myelocytes, 1.1% meta, 3.2% band, 73.6% segments),
and elevated C-reactive protein (CRP; 8.43 mg/dL)
were noted soon after admission. After a brief discussion
with the family and pediatricians, tocolysis was stopped
for apparent signs of chorioamnionitis and inevitable
labor progression. A premature female infant weighing
1,118 g was spontaneously delivered 3 hours after
admission. Apgar scores were 1, 5 and 7, at 1, 5 and 10
minutes, respectively, after aggressive resuscitation and
intubation.
Polymorphonuclear (PMN) cells were found in gastric
juice aspirate. Empirical antibiotics were prescribed
immediately for possible congenital pneumonia and
sepsis. Grade II respiratory distress syndrome (RDS) was
noted and surfactant therapy was given once. There-
after, the infant received ventilation at a low setting.
However, frequent cyanosis and lung atelectasis devel-
oped. It was difficult to wean her from the respirator.
Chest X-ray revealed a diffuse interstitial pattern of
cystic change early in the third week (Figure 1). Basal
hyperinflation with residual atelectasis in the upper
lungs developed in the fourth week (Figure 2). Early
chronic lung change was found, and WMS was
diagnosed. A bronchodilator, diuretics, and empirical
antibiotics were used to improve the respiratory
symptoms. Intravenous steroid therapy was also
prescribed under the impression of WMS, but was
stopped on the sixth day due to suspected sepsis.
Inhaled steroid therapy was added after sepsis was
controlled.
After intensive chest care and medical treatment,
slow weaning from the ventilator was initiated.
Respirator support was discontinued on the 35th day
after birth because the respiratory condition had
improved. Lung atelectasis had also resolved, as shown
on chest X-ray, but chronic lung changes were still
present. In addition, she had congenital ileal atresia
and underwent laparotomy and ileostomy on the 12th
day after birth. She remained in hospital to adjust her
feeding program.
The postpartum course of the mother was smooth.
Fever subsided gradually, and the hemogram and CRP
level returned to normal 3 days after delivery. Parenteral
ceftazidime was continued for 14 days on the suggestion
of the infection specialist. The mother was discharged
uneventfully on the 7th postpartum day. Pathologic
examination of the placental tissue showed sub-
chorionic fibrin clot deposition with focal membrane
infarction and necrosis, accompanied by suppurative
inflammation. The cord and villi were unremarkable.
Chorioamnionitis with focal infarction was diagnosed
histologically.
Figure 1. Chest X-ray shows diffuse fine interstitial cystic
pattern in the early stage.
Figure 2. Atelectasis in upper lungs and hyperaeration in basal
lungs.
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Discussion
Chorioamnionitis is defined as an intrauterine infection
that affects tissues of either mixed fetal–maternal
origin (the choriodecidual space and placenta) or fetal
origin (chorioamniotic membrane, amniotic fluid, and
umbilical cord) [1]. The incidence of chorioamnionitis
is highest at 24 weeks of gestation and lowest at term or
later [3]. Most commonly involved pathogens are species
of low virulence and of vaginal origin, such as Ureaplasma
urealyticum, Mycoplasma hominis, Fusobacterium spp., and
Streptococcus spp. [1]. The symptoms and signs of
chorioamnionitis include maternal fever, maternal or
fetal tachycardia, uterine tenderness, malodorous
amniotic fluid, and maternal leukocytosis or a raised
CRP level [1]. Unfortunately, fever is the only reliable
indicator for diagnosis [4]. Maternal leukocytosis
alone is unreliable. If chorioamnionitis is diagnosed,
antimicrobial therapy and prompt effort to effect
delivery, preferably vaginally, should be initiated [4,5].
Chorioamnionitis may activate the complement
system and increase the production of cytokines
(interleukins-1, -6 and -8, and tumor necrosis factor)
and immunoglobulin M (IgM) [1,3,6]. It can stimulate
the adrenocorticotropic hormone–cortisol axis to ac-
celerate surfactant production, thereby enhancing fetal
lung maturity. But it also recruits PMN cells and damages
the lining cells in the airway in conjunction with pro-
inflammatory cytokines. Therefore, chorioamnionitis
decreases the incidence of RDS in the newborn but
increases the risk of chronic lung disease at the same
time.
WMS is a specific type of chronic lung disease as-
sociated with chorioamnionitis. It was first reported by
Wilson and Mikity in 1960. The clinical symptoms are
insidious onset of progressive tachypnea, cyanosis, and
chest retractions after the first week and before 4 weeks
of age. Infants with initial mild RDS and who recover are
symptom-free for at least 72 hours. The incidence of
WMS in Western countries has been reported to be
much less in recent years, but in Japan, about 4.8–8.7%
of very low birth weight infants have been reported to
have WMS [6]. Generally, WMS has a better prognosis
than other etiologies of chronic lung disease [3,6,7].
Although the etiology remains unknown, the responsible
mechanism is thought to be intrauterine inflammation
rather than intrauterine infection alone. Infants with
WMS have elevated serum levels of complement and
IgM, which suggests a fetal immunologic response to
intrauterine infection. This leads to release of PMN-
elastase and destruction of elastin in the terminal airways
of the premature lung [3,6,8]. Finally, the typical picture
of emphysematous lung changes develops within 4
weeks of birth. There is an abnormal air distribution
with a disturbance in ventilation/perfusion in WMS.
Chest radiography usually shows a diffuse fine interstitial
cystic change throughout the entire lung at an early
stage, followed by development of basal emphysema
and residual atelectasis in the upper lobes [9].
The diagnosis of WMS in our case was based on
maternal history and the early onset of typical chest X-
ray findings, as well as the specific clinical presentations.
Another differential diagnosis in this patient was RDS
plus congenital pneumonia. However, the incidence of
RDS is generally low in newborns from mothers with
chorioamnionitis and will improve soon after surfactant
therapy. Thus, the likelihood of RDS in this case was
low. The timing of symptom onset, clinical mani-
festations, and responsiveness to steroid therapy all
pointed towards the diagnosis of WMS.
In conclusion, WMS is a chronic lung disease of
the newborn related to the intrauterine inflammatory
process in chorioamnionitis. When obstetricians manage
patients with chorioamnionitis, such neonatal com-
plications should be kept in mind and explained to
patients.
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